BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Orthop. Oct 18, 2026; 17(10): 126605
Published online Oct 18, 2026. doi: 10.5312/wjo.126605
Table 2 Summary of available evidence evaluating sympathetic nerve blocks in complex regional pain syndrome[12,18,31,33,35-37]
Ref.
Study type
Population
Arthroplasty specific
Block type
Take-home message
Duration of relief
Key limitations
Ferraro et al[31]Overview of systematic reviewsAdults with CRPSGeneral CRPSMultiple interventions including sympathetic blockadeEvidence remains low certainty; definitive benefit unclearVariableLimited high-quality trials
Lee et al[33]Retrospective cohortLower-extremity CRPSGeneral CRPSLumbar sympathetic block with botulinum toxin A/BType B toxin produced longer pain reliefApproximately 15 days (type A) vs approximately 69 days (type B)Small sample size; non-arthroplasty population
Hartrick et al[35]Prospective observational studyCRPS patientsGeneral CRPSSympathetic blockEarly response associated with better outcomesVariableNo standardized protocol; heterogenous population
Adam et al[12]Case reportMultiple revision THATHASympathetic blockMarked pain reduction after failed treatmentsPain free at 6 monthsSingle case report
Zanotti et al[36]Case reportElective THA patientsTHASympathetic blockProgressive symptom resolutionResolution by 8 months, symptom free at 6-year follow-upVery small sample size
Royeca et al[37]Case reportPost-TKA CRPSTKAMultimodal management (limited block data)Highlights diagnostic difficulty and variable outcomesVariableLimited evidence; primarily descriptive
Harden et al[18]Evidence-based reviewCRPS patientsGeneral CRPSSympathetic blockadeMay provide temporary pain relief and facilitate rehabilitation VariableLimited high-quality evidence; variable response


Write to the Help Desk